MENA Health Tech 50: Israel and UAE Dominate Over 80% of Regional Startup Activity

The Middle East and North Africa (MENA) region’s health tech landscape is rapidly evolving, but a new report from HolonIQ reveals a striking concentration of activity. The 2023 MENA Health Tech 50, which ranks the most promising health tech startups spanning digital health, biotech, and medtech, shows that Israel and the United Arab Emirates together account for more than 80% of the region’s startup activity. Meanwhile, business-to-business (B2B) models continue to dominate over direct-to-consumer (D2C) approaches, even as the latter gains some traction. This article unpacks the economic logic behind this concentration, explores what it means for healthcare supply chains and talent distribution across the region, and identifies emerging opportunities in other MENA nations.

[IMAGE: Infographic showing the percentage breakdown of startups by country from the HolonIQ list, with Israel and UAE highlighted in bright teal and deep blue, and smaller slices for Saudi Arabia, Egypt, Morocco, and others.]

The Geography of Health Tech: A Tale of Two Hubs

HolonIQ’s list covers startups across the full spectrum of health innovation—from telemedicine platforms and AI-powered diagnostics to hospital management software and biotech R&D. Yet the geographic distribution is anything but even. Israel alone represents roughly half of the identified startups, with the UAE contributing another third. The remaining 15-20% is scattered across Saudi Arabia, Egypt, Morocco, Qatar, and a handful of other countries.

This pattern is not coincidental. Israel’s health tech ecosystem has long been fueled by a strong research and development infrastructure, a culture of early-stage venture capital, and spillover from military technology. Companies like Zebra Medical Vision, K Health, and TytoCare have become household names in digital health globally. The UAE, for its part, has leveraged its status as a regional business hub, offering attractive free zones, a stable regulatory environment, and government-driven transformation agendas such as Dubai Health Strategy 2026 and the Abu Dhabi Department of Health’s digital health initiatives.

Both nations enjoy high smartphone penetration and a population willing to adopt digital health solutions—a combination that creates fertile ground for selling to hospitals and insurers. But the concentration also hints at a “two-speed” MENA ecosystem: Israel and the UAE function as mature hubs, while countries like Egypt, Morocco, and Saudi Arabia are still building foundational infrastructure in healthcare digitization, regulatory frameworks, and startup funding.

[IMAGE: Side-by-side comparison of key health tech enablers in Israel and UAE—funding per capita, number of active accelerators, regulatory sandboxes, and tech talent pool—with brief annotations.]

Why B2B Dominates—and Why It Matters

One of the most revealing findings in the 2023 MENA Health Tech 50 is the dominance of B2B business models. More than 70% of the listed startups operate primarily through sales to hospitals, clinics, insurance companies, or government health ministries. D2C telemedicine apps and wellness platforms, though growing, remain a smaller slice of the pie.

The rationale is deeply economic. In most MENA countries, healthcare is either publicly funded or dominated by large private hospital groups. Procurement cycles are long, but once a contract is secured, revenue streams are predictable and scalable. B2B solutions—such as hospital management platforms, diagnostic AI tools, and telemedicine infrastructure—address the acute pain points of overburdened public systems and efficiency-seeking private providers.

D2C health tech, by contrast, faces significant hurdles. Payment systems are fragmented: few consumers have robust health insurance, out-of-pocket spending is the norm in many countries, and cultural norms around self-diagnosis or remote consultation vary widely. In Egypt, for example, cash-on-delivery remains the primary payment method for many digital services, complicating subscription models. In Saudi Arabia, the recent rollout of mandatory health insurance for expatriates has opened some doors for D2C, but adoption remains modest.

The B2B tilt has long-term implications. If the region’s health tech supply chain becomes locked into a “vendor-to-hospital” model, it may limit direct patient empowerment. Patients might become passive recipients of technology rather than active users of personal health data or digital self-care tools. However, regulatory changes—such as the UAE’s Data Protection Law or Saudi Arabia’s push for unified electronic health records—could gradually shift the balance.

[IMAGE: Diagram illustrating B2B vs D2C revenue flows in MENA healthcare. On the left, B2B arrows from startups to hospitals/insurers then to patients; on the right, D2C arrows directly from startups to patients with a “fragmented payment” barrier icon.]

The Ripple Effects on Supply Chains and Talent

The concentration of health tech activity in Israel and the UAE has broader consequences for the entire region’s healthcare innovation ecosystem. Supply chains for medical devices, diagnostic kits, and digital infrastructure are increasingly designed around these two hubs. Israeli companies often serve as R&D powerhouses, while UAE-based firms handle regional distribution, regulatory approvals, and go-to-market strategies.

This creates a dependency that can be both a strength and a vulnerability. For startups in smaller markets like Jordan, Tunisia, or Oman, access to the Israeli or UAE ecosystem can provide critical funding, mentorship, and partnership opportunities. Yet it also means that talent tends to flow toward these hubs. Graduates from universities in Cairo, Rabat, or Riyadh who are trained in health informatics or biomedical engineering frequently relocate to Tel Aviv or Dubai for higher salaries and more dynamic startup environments.

The resulting brain drain risks leaving emerging markets with a shortage of local expertise needed to build homegrown health tech solutions. Countries like Morocco, which has a growing but still small startup scene, face an uphill battle in retaining talent while competing with the scale and vibrancy of the established hubs.

[IMAGE: A map of the MENA region with arrows representing talent migration flows from Egypt, Jordan, and Morocco into Israel and UAE. Overlaid with a small line chart showing the growth of health tech job postings in each country over 2019–2023.]

Emerging Hubs: Saudi Arabia, Egypt, Morocco, and Beyond

Despite the dominance of Israel and the UAE, there are signs of a next wave forming. Saudi Arabia’s Vision 2030 reforms have placed healthcare digitization at the center of the national agenda. The Ministry of Health has launched ambitious programs to digitize all public hospitals by 2025, and the Saudi Venture Capital Company is actively co-investing in health tech startups. Companies like Vezeeta (a telemedicine provider originally from Egypt, now strong in Saudi) and Nala (a mental health platform) are gaining traction.

Egypt, with its large population and rising burden of chronic diseases such as diabetes and hypertension, is seeing a surge of early-stage startups focused on logistics, pharmacy delivery, and telemedicine. The Egyptian government has introduced a new health insurance law that mandates digital records, creating a regulatory push for B2B solutions. Startups like Yodawy (digital pharmacy) and Alnmbr (hospital management) are among those attracting attention from regional and international investors.

Morocco, meanwhile, has a smaller ecosystem but benefits from strong ties to France and growing interest from international development organizations. The country’s healthcare system is underfunded but eager to adopt low-cost digital tools, particularly in maternal and child health. Startups like DabaDoc (doctor booking) and Med.tn (telemedicine) have shown that lightweight, mobile-first solutions can work even in less digitized environments.

Yet these markets face real hurdles. Access to growth-stage capital remains limited—most funding in Egypt and Morocco comes from early-stage angel investors or government grants, not large VC rounds. Regulatory uncertainty, especially around data privacy and cross-border health data flows, slows down product launches. And the cultural shift toward digital health literacy is still in progress.

[IMAGE: Bar chart comparing key indicators across Saudi Arabia, Egypt, Morocco, and UAE/Israel: total health tech startup count, average deal size (USD), regulatory readiness score, and smartphone penetration.]

What This Means for Investors and Policymakers

The HolonIQ 2023 MENA Health Tech 50 provides a snapshot, but its implications stretch far beyond the list. For investors, the concentration in Israel and the UAE signals that the most mature, de-risked opportunities remain in those two markets. However, the higher valuations and competition mean that finding undiscovered gems increasingly requires looking at emerging hubs. Saudi Arabia, with its government-backed demand and growing VC ecosystem, is arguably the most promising next market for B2B health tech. Egypt offers demographic scale and a low-cost operational base, while Morocco could become a testing ground for frugal innovation that might later expand across North Africa.

For policymakers, the data underscores the urgency of building enabling infrastructure in under-indexed countries. That means not just regulatory sandboxes and free zones, but also investments in digital literacy, interoperability standards for electronic health records, and incentives for local talent to stay. Without such efforts, the “two-speed” MENA health tech ecosystem may harden into a permanent divide, leaving millions of patients in slower-moving markets without access to the innovations that could transform their care.

The B2B dominance also calls for strategic thinking. If governments want to foster D2C models that empower patients directly, they may need to address payment fragmentation, subsidize health insurance for low-income populations, and launch public awareness campaigns about the safety and efficacy of remote care. At the same time, B2B vendors should be encouraged to develop APIs and open platforms that allow patient-facing applications to plug into existing hospital systems, creating a more connected ecosystem.

[IMAGE: A stylized vector illustration of the MENA region map with glowing dots representing health tech startups. Two large, bright clusters over Israel and the UAE with connecting lines. A small inset bar chart showing B2B vs D2C dominance. Deep blue and teal color palette, no text or watermarks.]

Outlook: A Region in Transition

The 2023 MENA Health Tech 50 is a barometer, not a final verdict. Health tech is still in its early innings across the region, and the current dominance of two countries may not be permanent. As Saudi Arabia accelerates its digital transformation, as Egypt’s population pressures drive demand for scalable solutions, and as Morocco and other nations find their niches, the map will inevitably become more multipolar.

But for now, Israel and the UAE remain the twin engines propelling the region’s health tech ecosystem. Their capacity to produce B2B solutions that solve real institutional problems has created a template that other markets are beginning to emulate. The question is whether the rest of MENA can catch up—or whether the concentration will deepen, creating an uneven landscape that serves some populations far better than others. The next few years of venture capital flows, regulatory reforms, and talent migration will provide the answer.